These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
356 related items for PubMed ID: 15831275
1. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma. Lencioni R, Crocetti L. Clin Liver Dis; 2005 May; 9(2):301-14, viii. PubMed ID: 15831275 [Abstract] [Full Text] [Related]
2. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial. Akamatsu M, Yoshida H, Obi S, Sato S, Koike Y, Fujishima T, Tateishi R, Imamura M, Hamamura K, Teratani T, Shiina S, Ishikawa T, Omata M. Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514 [Abstract] [Full Text] [Related]
3. Local ablation therapy for hepatocellular carcinoma. From ethanol injection to radiofrequency ablation. Shiina S, Tateishi R, Yoshida H, Kanai F, Omata M. Saudi Med J; 2007 Jun; 28(6):831-7. PubMed ID: 17530094 [Abstract] [Full Text] [Related]
4. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm. Vallone P, Catalano O, Izzo F, Siani A. Cardiovasc Intervent Radiol; 2006 Jun; 29(4):544-51. PubMed ID: 16528626 [Abstract] [Full Text] [Related]
5. Percutaneous ablation for small hepatocellular carcinoma. Yin XY, Lu MD. Expert Rev Gastroenterol Hepatol; 2009 Apr; 3(2):121-30. PubMed ID: 19351283 [Abstract] [Full Text] [Related]
14. Obesity did not diminish the efficacy of percutaneous ablation for hepatocellular carcinoma. Ohki T, Tateishi R, Shiina S, Sato T, Masuzaki R, Yoshida H, Kanai F, Obi S, Yoshida H, Omata M. Liver Int; 2007 Apr; 27(3):360-7. PubMed ID: 17355458 [Abstract] [Full Text] [Related]